HSBC Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.5M Buy
373,117
+47,083
+14% +$2.58M 0.01% 626
2025
Q1
$23M Buy
326,034
+130,504
+67% +$9.21M 0.01% 605
2024
Q4
$12.8M Sell
195,530
-4,865
-2% -$320K 0.01% 736
2024
Q3
$14.1M Buy
200,395
+110,600
+123% +$7.77M 0.01% 724
2024
Q2
$7.41M Sell
89,795
-142,903
-61% -$11.8M ﹤0.01% 807
2024
Q1
$20.3M Sell
232,698
-196,359
-46% -$17.1M 0.01% 644
2023
Q4
$41.3M Sell
429,057
-178,041
-29% -$17.2M 0.04% 440
2023
Q3
$53.9M Buy
607,098
+434,199
+251% +$38.6M 0.06% 330
2023
Q2
$15M Sell
172,899
-18,888
-10% -$1.64M 0.02% 639
2023
Q1
$18.7M Sell
191,787
-104,788
-35% -$10.2M 0.02% 567
2022
Q4
$30.4M Buy
296,575
+195,495
+193% +$20M 0.03% 458
2022
Q3
$8.62M Buy
101,080
+44,955
+80% +$3.84M 0.01% 812
2022
Q2
$4.68M Sell
56,125
-28,150
-33% -$2.35M 0.01% 1040
2022
Q1
$6.53M Buy
84,275
+34,713
+70% +$2.69M 0.01% 922
2021
Q4
$4.41M Sell
49,562
-35,335
-42% -$3.14M ﹤0.01% 1043
2021
Q3
$6.56M Buy
84,897
+31,007
+58% +$2.4M 0.01% 854
2021
Q2
$4.49M Buy
53,890
+11,160
+26% +$930K ﹤0.01% 919
2021
Q1
$3.23M Sell
42,730
-5,478
-11% -$414K ﹤0.01% 958
2020
Q4
$4.2M Sell
48,208
-21,535
-31% -$1.88M 0.01% 854
2020
Q3
$5.33M Buy
69,743
+27,931
+67% +$2.14M 0.01% 731
2020
Q2
$5.16M Sell
41,812
-11,739
-22% -$1.45M 0.01% 689
2020
Q1
$4.49M Buy
53,551
+20,266
+61% +$1.7M 0.01% 701
2019
Q4
$2.82M Sell
33,285
-8,285
-20% -$702K ﹤0.01% 968
2019
Q3
$2.8M Buy
41,570
+15,493
+59% +$1.04M 0.01% 975
2019
Q2
$2.23M Sell
26,077
-11,107
-30% -$951K ﹤0.01% 1026
2019
Q1
$3.3M Sell
37,184
-238,585
-87% -$21.2M 0.01% 919
2018
Q4
$23.5M Buy
275,769
+55,006
+25% +$4.68M 0.04% 302
2018
Q3
$21.4M Buy
220,763
+199,861
+956% +$19.4M 0.03% 395
2018
Q2
$1.97M Sell
20,902
-16,890
-45% -$1.59M ﹤0.01% 1101
2018
Q1
$3.06M Sell
37,792
-1,450
-4% -$118K ﹤0.01% 929
2017
Q4
$3.5M Buy
39,242
+13,724
+54% +$1.22M 0.01% 913
2017
Q3
$2.37M Sell
25,518
-720
-3% -$67K ﹤0.01% 911
2017
Q2
$2.38M Buy
26,238
+8,184
+45% +$743K ﹤0.01% 898
2017
Q1
$1.59M Sell
18,054
-18,635
-51% -$1.64M ﹤0.01% 966
2016
Q4
$3.04M Sell
36,689
-6,903
-16% -$572K 0.01% 809
2016
Q3
$4.03M Sell
43,592
-4,858
-10% -$449K 0.01% 739
2016
Q2
$3.77M Sell
48,450
-32,585
-40% -$2.54M 0.01% 764
2016
Q1
$6.68M Sell
81,035
-125
-0.2% -$10.3K 0.02% 629
2015
Q4
$8.5M Sell
81,160
-19,406
-19% -$2.03M 0.02% 584
2015
Q3
$10.6M Sell
100,566
-3,741
-4% -$394K 0.03% 521
2015
Q2
$14.2M Buy
104,307
+42,580
+69% +$5.81M 0.03% 496
2015
Q1
$7.69M Buy
61,727
+10,967
+22% +$1.37M 0.01% 651
2014
Q4
$4.59M Buy
50,760
+14,280
+39% +$1.29M 0.01% 733
2014
Q3
$2.63M Sell
36,480
-296,822
-89% -$21.4M 0.01% 872
2014
Q2
$20.7M Buy
333,302
+98,803
+42% +$6.15M 0.04% 357
2014
Q1
$16M Buy
234,499
+218,010
+1,322% +$14.9M 0.04% 380
2013
Q4
$1.16M Buy
16,489
+6,098
+59% +$429K ﹤0.01% 971
2013
Q3
$750K Buy
10,391
+8,438
+432% +$609K ﹤0.01% 1060
2013
Q2
$109K Buy
+1,953
New +$109K ﹤0.01% 1273